--- title: "12 Health Care Stocks Moving In Wednesday's Intraday Session" type: "News" locale: "en" url: "https://longbridge.com/en/news/297815513.md" description: "During Wednesday's intraday session, several healthcare stocks experienced significant volatility. Top gainers included bioAffinity Technologies (up 54.3%), Gelteq (up 41.4%), and Purple Biotech (up 37.27%). Conversely, notable losers were TScan Therapeutics (down 42.7%), CDT Equity (down 35.48%), and Can Fite Biopharma (down 23.71%). The report highlights substantial price movements across various small-cap biotech and health care companies." datetime: "2026-09-02T17:06:34.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/297815513.md) - [en](https://longbridge.com/en/news/297815513.md) - [zh-HK](https://longbridge.com/zh-HK/news/297815513.md) generator: "portal-rs" --- # 12 Health Care Stocks Moving In Wednesday's Intraday Session ### Gainers - **bioAffinity Technologies** (NASDAQ:BIAF) stock moved upwards by 54.3% to $10.17 during Wednesday's regular session. The company's market cap stands at $3.9 million. - **Gelteq** (NASDAQ:GELS) shares increased by 41.4% to $0.75. The market value of their outstanding shares is at $5.6 million. - **Purple Biotech** (NASDAQ:PPBT) stock moved upwards by 37.27% to $2.28. The company's market cap stands at $1.5 million. - **ENDRA Life Sciences** (NASDAQ:NDRA) shares rose 21.06% to $6.38. The market value of their outstanding shares is at $7.9 million. - **OmniAb** (NASDAQ:OABI) stock moved upwards by 19.7% to $5.32. The company's market cap stands at $643.6 million. - **Definitive Healthcare** (NASDAQ:DH) shares rose 15.81% to $1.04. The market value of their outstanding shares is at $96.3 million. ### Losers - **TScan Therapeutics** (NASDAQ:TCRX) stock declined by 42.7% to $0.38 during Wednesday's regular session. The company's market cap stands at $45.1 million. - **CDT Equity** (NASDAQ:CDT) shares declined by 35.48% to $0.95. The market value of their outstanding shares is at $1.1 million. - **Can Fite Biopharma** (AMEX:CANF) shares fell 23.71% to $2.51. The company's market cap stands at $7.0 million. - **Apimeds Pharmaceuticals** (AMEX:APUS) shares fell 21.76% to $2.77. The market value of their outstanding shares is at $5.3 million. - **Lakewood-Amedex** (NASDAQ:LABT) shares fell 15.95% to $2.32. The market value of their outstanding shares is at $6.5 million. - **BioXcel Therapeutics** (NASDAQ:BTAI) shares declined by 15.48% to $0.12. The company's market cap stands at $4.2 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/ This article was generated by Benzinga's automated content engine and reviewed by an editor. ### Related Stocks - [BIAFW.US](https://longbridge.com/en/quote/BIAFW.US.md) - [TCRX.US](https://longbridge.com/en/quote/TCRX.US.md) - [PPBT.US](https://longbridge.com/en/quote/PPBT.US.md) - [CDT.US](https://longbridge.com/en/quote/CDT.US.md) - [BIAF.US](https://longbridge.com/en/quote/BIAF.US.md) - [GELS.US](https://longbridge.com/en/quote/GELS.US.md) - [CANF.US](https://longbridge.com/en/quote/CANF.US.md) - [NDRA.US](https://longbridge.com/en/quote/NDRA.US.md) - [OABI.US](https://longbridge.com/en/quote/OABI.US.md) - [DH.US](https://longbridge.com/en/quote/DH.US.md) - [APUS.US](https://longbridge.com/en/quote/APUS.US.md) - [LABT.US](https://longbridge.com/en/quote/LABT.US.md) - [BTAI.US](https://longbridge.com/en/quote/BTAI.US.md) - [29273B500.US](https://longbridge.com/en/quote/29273B500.US.md) - [OABIW.US](https://longbridge.com/en/quote/OABIW.US.md) - [CDTTW.US](https://longbridge.com/en/quote/CDTTW.US.md) ## Related News & Research - [BioAffinity Technologies Stock Surges Following Hong Kong Patent Grant](https://longbridge.com/en/news/299359121.md) - [CDT Equity Partners With QIMA Life Sciences On Autoimmune Skin Research, Shares Fall In Pre-market](https://longbridge.com/en/news/299443550.md) - [CANF: Longer-than-expected survival in liver cancer and narrowed net loss mark H1 2026 results](https://longbridge.com/en/news/298966883.md) - [CDT Equity issues USD 2.13 million senior secured convertible note to J.J. Astor & Co](https://longbridge.com/en/news/299490083.md) - [BioAffinity Advances Noninvasive CyPath Lung Test For Post-Treatment Monitoring](https://longbridge.com/en/news/297683429.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**